2-[(cyclohexylcarbonyl)amino]-4,5,6,7-tetrahydrobenzo[b]-thiophene-3-carbonitrile

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 2-[(cyclohexylcarbonyl)amino]-4,5,6,7-tetrahydrobenzo[b]-thiophene-3-carbonitrile
• 英文别名: N-(3-cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)cyclohexanecarboxamide
• 化学式: C₁₆H₂₀N₂OS
• 分子量: 288.414
• InChiKey: HABPUSRRADTLAQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.7
• 重原子数：
  20
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.62
• 拓扑面积：
  81.1
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  环己酮 在 吗啉 、 1,2,3,4,5,6,7,8-八硫杂环辛烷 、 4-二甲氨基吡啶 、 N,N'-二异丙基碳二亚胺 作用下， 以 乙醇 、 二氯甲烷 为溶剂， 生成 2-[(cyclohexylcarbonyl)amino]-4,5,6,7-tetrahydrobenzo[b]-thiophene-3-carbonitrile
  参考文献：
  名称：

  Synthesis and Pharmacological Characterization of 2-(Acylamino)thiophene Derivatives as Metabolically Stable, Orally Effective, Positive Allosteric Modulators of the GABA_B Receptor

  摘要：

  Two recently reported hit compounds, COR627 and COR628, underpinned the development of a series of 2-(acylamino)thiophene derivatives. Some of these compounds displayed significant activity in vitro as positive allosteric modulators of the GABA(B) receptor by potentiating GTP gamma S stimulation induced by GABA at 2.5 and 25 mu M while failing to exhibit intrinsic agonist activity. Compounds were also found to be effective in vivo, potentiating baclofen-induced sedation/hypnosis in DBA mice when administered either intraperitoneally or intragastrically. Although displaying a lower potency in vitro than the reference compound GS39783, the new compounds 6, 10, and 11 exhibited a higher efficacy in vivo: combination of these compounds with a per se nonsedative dose of baclofen resulted in shorter onset and longer duration of the loss of righting reflex in mice. Test compounds showed cytotoxic effects at concentrations comparable to or higher than those of GS39783 or BHF177.

  DOI：

  10.1021/jm400144w

文献信息

• N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3
  作者：Richard M. Angell、Francis L. Atkinson、Murray J. Brown、Tsu Tshen Chuang、John A. Christopher、Maria Cichy-Knight、Allison K. Dunn、Kendra E. Hightower、Susanna Malkakorpi、James R. Musgrave、Margarete Neu、Paul Rowland、Robyn L. Shea、Jeffery L. Smith、Donald O. Somers、Sonia A. Thomas、Gladstone Thompson、Ruolan Wang

  DOI：10.1016/j.bmcl.2006.12.003

  日期：2007.3

  The identification and exploration of a novel, potent and selective series of N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien2-yl)amide inhibitors of JNK2 and JNK3 kinases is described. Compounds 5a and 11a were identified as potent inhibitors of JNK3 (pIC(50) 6.7 and 6.6, respectively), with essentially equal potency against JNK2 (pIC(50) 6.5). Selectivity within the mitogen-activated protein kinase (MAPK) family, against JNK1, p38 alpha and ERK2, was observed for the series. X-ray crystallography of 5e and 8a in JNK3 revealed a unique binding mode, with the 3-cyano substituent forming an H-bond acceptor interaction with the hinge region of the ATP-binding site. (c) 2006 Elsevier Ltd. All rights reserved.
• Identification and optimization of small molecule antagonists of vasoactive intestinal peptide receptor-1 (VIPR1)
  作者：Lalgudi S. Harikrishnan、Neelam Srivastava、Lauren E. Kayser、David S. Nirschl、Kumaragurubaran K、Amrita Roy、Anuradha Gupta、Sukhen Karmakar、Tajudheen Karatt、Arvind Mathur、Neil T. Burford、Jing Chen、Yan Kong、MaryEllen Cvijic、Christopher B. Cooper、Michael A. Poss、George L. Trainor、Tai W. Wong

  DOI：10.1016/j.bmcl.2012.01.082

  日期：2012.3

  Identification, synthesis and structure-activity relationship of small-molecule VIPR1 antagonists encompassing two chemical series are described. (C) 2012 Elsevier Ltd. All rights reserved.
• Synthesis and Pharmacological Characterization of 2-(Acylamino)thiophene Derivatives as Metabolically Stable, Orally Effective, Positive Allosteric Modulators of the GABA_B Receptor
  作者：Claudia Mugnaini、Valentina Pedani、Angelo Casu、Carla Lobina、Alberto Casti、Paola Maccioni、Alessandra Porcu、Daniela Giunta、Stefania Lamponi、Maurizio Solinas、Stefania Dragoni、Massimo Valoti、Giancarlo Colombo、Maria Paola Castelli、Gian Luigi Gessa、Federico Corelli

  DOI：10.1021/jm400144w

  日期：2013.5.9

  Two recently reported hit compounds, COR627 and COR628, underpinned the development of a series of 2-(acylamino)thiophene derivatives. Some of these compounds displayed significant activity in vitro as positive allosteric modulators of the GABA(B) receptor by potentiating GTP gamma S stimulation induced by GABA at 2.5 and 25 mu M while failing to exhibit intrinsic agonist activity. Compounds were also found to be effective in vivo, potentiating baclofen-induced sedation/hypnosis in DBA mice when administered either intraperitoneally or intragastrically. Although displaying a lower potency in vitro than the reference compound GS39783, the new compounds 6, 10, and 11 exhibited a higher efficacy in vivo: combination of these compounds with a per se nonsedative dose of baclofen resulted in shorter onset and longer duration of the loss of righting reflex in mice. Test compounds showed cytotoxic effects at concentrations comparable to or higher than those of GS39783 or BHF177.